Literature DB >> 12422940

Methamphetamine use and HIV risk among substance-abusing offenders in California.

David Farabee1, Michael Prendergast, Jerome Cartier.   

Abstract

Recent epidemiological surveys of illicit substance use show a particularly high prevalence of methamphetamine use in the western and southwestern United States-most notably California. Moreover, in their analysis of 1995 Drug Use Forecasting data, Anglin and colleagues (1998) found that methamphetamine was a preferred substance among California arrestees. The present study uses data from 807 state prison inmates in California (32% of whom reported using methamphetamine prior to incarceration) to examine the associations between methamphetamine use and HIV risk behaviors. Methamphetamine users in this sample were significantly more likely than nonusers to have injected drugs during the six months prior to their current incarceration. Among injectors, however, injection-related risks (such as dirty needles and needle sharing, etc.) were not significantly associated with methamphetamine use. However, past six-month sex-related risks were dramatically higher for methamphetamine users. These patterns persisted even after controlling for background differences between the two groups. The results of this study underscore the importance of addressing the higher sex-related HIV/AIDS risk among methamphetamine users undergoing prison-based drug treatment.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12422940     DOI: 10.1080/02791072.2002.10399966

Source DB:  PubMed          Journal:  J Psychoactive Drugs        ISSN: 0279-1072


  22 in total

1.  Injection drug use among stimulant users in a national sample.

Authors:  Li-Tzy Wu; Daniel J Pilowsky; Wendee M Wechsberg; William E Schlenger
Journal:  Am J Drug Alcohol Abuse       Date:  2004       Impact factor: 3.829

2.  Predictors of condom use among a sample of male inmates: a social cognitive perspective.

Authors:  Torrance T Stephens; Ronald Braithwaite; Rhonda Conerly; Katrina Brantley
Journal:  J Natl Med Assoc       Date:  2006-04       Impact factor: 1.798

Review 3.  Behavior change and health-related interventions for heterosexual risk reduction among drug users.

Authors:  Salaam Semaan; Don C Des Jarlais; Rob Malow
Journal:  Subst Use Misuse       Date:  2006       Impact factor: 2.164

4.  Predictors of intention to change HIV sexual and injection risk behaviors among heterosexual methamphetamine-using offenders in drug treatment: a test of the AIDS Risk Reduction Model.

Authors:  Mary-Lynn Brecht; Judith Stein; Elizabeth Evans; Debra A Murphy; Douglas Longshore
Journal:  J Behav Health Serv Res       Date:  2008-01-24       Impact factor: 1.505

5.  Predictors of methamphetamine injection in out-of-treatment IDUs.

Authors:  Karen F Corsi; Carol F Kwiatkowski; Robert E Booth
Journal:  Subst Use Misuse       Date:  2009       Impact factor: 2.164

6.  Male methamphetamine-user inmates in prison treatment: during-treatment outcomes.

Authors:  George W Joe; Grace A Rowan-Szal; Jack M Greener; D Dwayne Simpson; Jerry Vance
Journal:  J Subst Abuse Treat       Date:  2009-10-03

7.  Binge use and sex and drug use behaviors among HIV(-), heterosexual methamphetamine users in San Diego.

Authors:  W Susan Cheng; Richard S Garfein; Shirley J Semple; Steffanie A Strathdee; James K Zians; Thomas L Patterson
Journal:  Subst Use Misuse       Date:  2010       Impact factor: 2.164

8.  The Feasibility of Interventions to Reduce HIV Risk and Drug Use among Heterosexual Methamphetamine Users.

Authors:  Karen F Corsi; Wayne E Lehman; Sung-Joon Min; Shannon P Lance; Nicole Speer; Robert E Booth; Steve Shoptaw
Journal:  J AIDS Clin Res       Date:  2012-06-04

Review 9.  Pharmacotherapy of amphetamine-type stimulant dependence: an update.

Authors:  Matthew Brensilver; Keith G Heinzerling; Steven Shoptaw
Journal:  Drug Alcohol Rev       Date:  2013-04-25

10.  The persistence of HIV risk behaviors among methamphetamine-using offenders.

Authors:  Jerome J Cartier; Lisa Greenwell; Michael L Prendergast
Journal:  J Psychoactive Drugs       Date:  2008-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.